Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
- PMID: 11793012
- DOI: 10.1007/s001250100020
Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence
Abstract
That cardiovascular disease occurs more frequently in patients with Type II (non-insulin-dependent) diabetes mellitus has been recognized for a long time. However, the extent to which hyperglycaemia contributes to atherosclerosis and cardiovascular disease is still not clear. Epidemiological studies published in recent years suggest that postprandial blood glucose might be an independent risk factor of cardiovascular disease. The main results of these studies, which are reviewed in this article, are that subjects from the general population with mild to moderate hyperglycaemia, following oral glucose load, but not in the fasting state, showed an increased cardiovascular risk. Furthermore, the post-challenge as well as postprandial glucose concentrations of subjects with Type II diabetes were found to be directly associated to incident cardiovascular disease independently of fasting glucose. Also, the correction of fasting hyperglycaemia or HbA1 c or both, disregarding the specific correction of postprandial hyperglycaemia was not found to significantly reduce the incidence of cardiovascular disease in patients with Type II diabetes. Finally, the strict control of both preprandial and postprandial hyperglycaemia yielded a substantial reduction of cardiovascular disease in Type II diabetes. Trials specifically designed to address this issue are needed to determine whether postprandial hyperglycaemia plays an independent and causative role in cardiovascular disease in patients with Type II diabetes.
Similar articles
-
[Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].Ugeskr Laeger. 2003 Aug 11;165(33):3149-53. Ugeskr Laeger. 2003. PMID: 12968409 Review. Danish.
-
Mechanisms of tissue damage in the postprandial state.Int J Clin Pract Suppl. 2001 Sep;(123):7-12. Int J Clin Pract Suppl. 2001. PMID: 11594300 Review.
-
Post-challenge hyperglycaemia is associated with premature death and macrovascular complications.Diabetologia. 2003 Mar;46 Suppl 1:M17-21. doi: 10.1007/s00125-002-0932-4. Epub 2002 Nov 7. Diabetologia. 2003. PMID: 12652354 Review.
-
Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.Ann Med. 2005;37(4):250-8. doi: 10.1080/07853890510037365. Ann Med. 2005. PMID: 16019723 Review.
-
Postprandial hyperglycaemia and cardiovascular complications of diabetes: an update.Nutr Metab Cardiovasc Dis. 2006 Oct;16(7):453-6. doi: 10.1016/j.numecd.2006.05.006. Epub 2006 Aug 24. Nutr Metab Cardiovasc Dis. 2006. PMID: 16934443
Cited by
-
Effect of low-glycemic load diet on changes in cardiovascular risk factors in poorly controlled diabetic patients.Indian J Endocrinol Metab. 2012 Nov;16(6):991-5. doi: 10.4103/2230-8210.103010. Indian J Endocrinol Metab. 2012. PMID: 23226649 Free PMC article.
-
Alleviating effects of lupeol on postprandial hyperglycemia in diabetic mice.Toxicol Res (Camb). 2021 May 8;10(3):495-500. doi: 10.1093/toxres/tfab019. eCollection 2021 May. Toxicol Res (Camb). 2021. PMID: 34141163 Free PMC article.
-
Dihydroquinazolin-4(1H)-one derivatives as novel and potential leads for diabetic management.Mol Divers. 2022 Apr;26(2):849-868. doi: 10.1007/s11030-021-10196-5. Epub 2021 Mar 1. Mol Divers. 2022. PMID: 33650031
-
Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes.Vasc Health Risk Manag. 2006;2(1):69-77. doi: 10.2147/vhrm.2006.2.1.69. Vasc Health Risk Manag. 2006. PMID: 17319471 Free PMC article. Review.
-
Effects of S21403 (mitiglinide) on postprandial generation of oxidative stress and inflammation in type 2 diabetic patients.Diabetologia. 2005 Sep;48(9):1919-24. doi: 10.1007/s00125-005-1849-5. Epub 2005 Jul 9. Diabetologia. 2005. PMID: 16007412 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous